soul trial oral semaglutide trial: 14 mg demonstrated superior reduction in risk of CV events ACC 25 Late-Breaking Discussion: SOUL:

Working hand-in-hand with my care team, we crafted a personalized plan, starting with the lowest possible dose and carefully progressing

The advantages of precision dosing through microdosing are multifaceted

My review of the available research seems to indicate that L-carnitine is considered a safe, affordable option but that, clearly, there is not a large or consistent enough body of evidence to make a strong claim for people living with NAFLD to consider this supplement a must

If passed, TROA would: Permanently allow Medicare Part D to cover FDA-approved anti-obesity medications Expand Medicare Part B coverage of intensive behavioral therapy for obesity to include a wider range of providers (not just primary care physicians) However, in April 2025, CMS announced it would not include Medicare Part D coverage of obesity drugs in its rule changes for 2026, stating the proposal was "not appropriate at this time." That decision pushed the issue back to Congress, where the TROA remains under consideration